Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386753502> ?p ?o ?g. }
- W4386753502 endingPage "106914" @default.
- W4386753502 startingPage "106914" @default.
- W4386753502 abstract "Immune checkpoint inhibitors (ICIs) are an expanding class of immunotherapeutic agents with the potential to cure cancer. Despite the outstanding clinical response in patient subsets, most individuals become refractory or develop resistance. Patient stratification and personalized immunotherapies are limited by the absence of predictive response markers. Recent findings show that dominant patterns of immune cell composition, T-cell status and heterogeneity, and spatiotemporal distribution of immune cells within the tumor microenvironment (TME) are becoming essential determinants of prognosis and therapeutic response. In this context, ICIs also function as investigational tools and proof of concept, allowing the validation of the identified mechanisms. After reviewing the current state of ICIs, this article will explore new comprehensive predictive markers for ICIs based on recent discoveries. We will discuss the recent establishment of a classification of TMEs into immune archetypes as a tool for personalized immune profiling, allowing patient stratification before ICI treatment. We will discuss the developing comprehension of T-cell diversity and its role in shaping the immune profile of patients. We describe the potential of strategies that score the mutual spatiotemporal modulation between T-cells and other cellular components of the TME. Additionally, we will provide an overview of a range of synthetic and naturally occurring or derived small molecules. We will compare compounds that were recently identified by in silico prediction to wet lab-validated drug candidates with the potential to function as ICIs and/or modulators of the cellular components of the TME." @default.
- W4386753502 created "2023-09-15" @default.
- W4386753502 creator A5018593253 @default.
- W4386753502 creator A5067297017 @default.
- W4386753502 creator A5089909449 @default.
- W4386753502 date "2023-10-01" @default.
- W4386753502 modified "2023-10-15" @default.
- W4386753502 title "Enhancing personalized immune checkpoint therapy by immune archetyping and pharmacological targeting" @default.
- W4386753502 cites W1528911741 @default.
- W4386753502 cites W1538902372 @default.
- W4386753502 cites W1540682053 @default.
- W4386753502 cites W1823628041 @default.
- W4386753502 cites W1859257957 @default.
- W4386753502 cites W1982488143 @default.
- W4386753502 cites W1996912024 @default.
- W4386753502 cites W2011458181 @default.
- W4386753502 cites W2037342985 @default.
- W4386753502 cites W2053404124 @default.
- W4386753502 cites W2086834665 @default.
- W4386753502 cites W2088110734 @default.
- W4386753502 cites W2088717724 @default.
- W4386753502 cites W2094366129 @default.
- W4386753502 cites W2097995306 @default.
- W4386753502 cites W2100039832 @default.
- W4386753502 cites W2116495352 @default.
- W4386753502 cites W2118471749 @default.
- W4386753502 cites W2127897152 @default.
- W4386753502 cites W2130030995 @default.
- W4386753502 cites W2148590804 @default.
- W4386753502 cites W2152897456 @default.
- W4386753502 cites W2201379305 @default.
- W4386753502 cites W2264492011 @default.
- W4386753502 cites W2264835212 @default.
- W4386753502 cites W2273119405 @default.
- W4386753502 cites W2280237901 @default.
- W4386753502 cites W2400022769 @default.
- W4386753502 cites W2412250098 @default.
- W4386753502 cites W2419639370 @default.
- W4386753502 cites W2465860350 @default.
- W4386753502 cites W2470200249 @default.
- W4386753502 cites W2529896336 @default.
- W4386753502 cites W2541574334 @default.
- W4386753502 cites W2545009331 @default.
- W4386753502 cites W2552983556 @default.
- W4386753502 cites W2587048937 @default.
- W4386753502 cites W2591493010 @default.
- W4386753502 cites W2603526557 @default.
- W4386753502 cites W2604812712 @default.
- W4386753502 cites W2605630275 @default.
- W4386753502 cites W2609921003 @default.
- W4386753502 cites W2612419201 @default.
- W4386753502 cites W2616761213 @default.
- W4386753502 cites W2622499649 @default.
- W4386753502 cites W2725858612 @default.
- W4386753502 cites W2745840031 @default.
- W4386753502 cites W2754465613 @default.
- W4386753502 cites W2763186529 @default.
- W4386753502 cites W2764232556 @default.
- W4386753502 cites W2766016099 @default.
- W4386753502 cites W2767199072 @default.
- W4386753502 cites W2779008743 @default.
- W4386753502 cites W2779221466 @default.
- W4386753502 cites W2785803176 @default.
- W4386753502 cites W2786031287 @default.
- W4386753502 cites W2797866384 @default.
- W4386753502 cites W2801309958 @default.
- W4386753502 cites W2802206159 @default.
- W4386753502 cites W2803508781 @default.
- W4386753502 cites W2805252210 @default.
- W4386753502 cites W2807859574 @default.
- W4386753502 cites W2808351116 @default.
- W4386753502 cites W2838357484 @default.
- W4386753502 cites W2867029731 @default.
- W4386753502 cites W2883970691 @default.
- W4386753502 cites W2886462153 @default.
- W4386753502 cites W2887577080 @default.
- W4386753502 cites W2887901772 @default.
- W4386753502 cites W2898830231 @default.
- W4386753502 cites W2899204048 @default.
- W4386753502 cites W2899805357 @default.
- W4386753502 cites W2902856530 @default.
- W4386753502 cites W2903493397 @default.
- W4386753502 cites W2909218971 @default.
- W4386753502 cites W2913289941 @default.
- W4386753502 cites W2918546246 @default.
- W4386753502 cites W2920927214 @default.
- W4386753502 cites W2924122631 @default.
- W4386753502 cites W2925815206 @default.
- W4386753502 cites W2928276758 @default.
- W4386753502 cites W2932352133 @default.
- W4386753502 cites W2939564206 @default.
- W4386753502 cites W2940591955 @default.
- W4386753502 cites W2943618951 @default.
- W4386753502 cites W2947548345 @default.
- W4386753502 cites W2948740360 @default.
- W4386753502 cites W2948884915 @default.
- W4386753502 cites W2952001837 @default.
- W4386753502 cites W2952815301 @default.